OMX30 1 645 0,2%  OMXH25 4 061 -0,6%  OMXC20 1 014 0,0%  Dow 21 395 0,0%  Nas 5 803 0,4%  EUR 9,7572 -0,2%  USD 8,7154 0,0%  Olja 45,8 0,3%  Guld 1 257 0,0% 

Smith & Nephew Aktie

13,69GBP -0,13GBP -0,94%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Smith & Nephew

2016 2017e 2018e 2019e 2020e
Utdelning 0,25 0,25 0,27 0,29 0,33
Direktavkastning (i %) 2,07 1,83 1,98 2,13 2,40
PE-tal 18,11 21,15 19,36 17,92 15,97
Resultat/aktie 0,66 0,65 0,71 0,77 0,86
ytterligare nyheter

Analyser om Smith & Nephew plc

ytterligare analyser

Smith & Nephew Peer Group

Fresenius Medical Care 87,64
-1,0%
Fresenius 78,24
-0,9%
Intuitive Surgical 948,50
-0,6%
STRATEC Biomedical 60,50
0,0%
Smith & Nephew 13,69
-0,9%
Stryker 141,13
-0,1%
Zimmer Biomet 129,11
-0,2%
pagehit

Lägg till instrument

Vad tycker du?

Profil Smith & Nephew plctill bolagsprofilen

Smith & Nephew Plc is a global orthopedics company. It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management. The company operates in two divisions: Advanced Surgical Devices and Advanced Wound Management. The Advanced Surgical Devices division offers, orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy and other ASD orthopaedic reconstruction includes hip implants, knee implants and ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery. Its trauma and extremities consists of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; sports medicine joint repair, offers surgeons a broad array of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints; arthroscopy enabling technologies offer healthcare providers a variety of technologies such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue; and other ASD includes gynaecological instrumentation and the remaining Clinical Therapies geographies which are in the process of being transferred to Bioventus. The Advanced Wound Devices division consists of traditional and single use negative pressure wound therapy, hydro surgery systems biologics and other bioactive technologies that provide unique approaches to debridement and dermal regeneration. Its products are used for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns and post-operative wounds. Smith & Nephew was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.

Realtidskurs Smith & Nephew plc

Bid
13,67
GBP
Ask
13,72
GBP
Kurstid
17:29
Börsen CHX

Aktiekurs Smith & Nephew plc i GBPPUSH CHART

Kurs 13,69 GBP -0,13 -0,94 %
Kurstid 17:35:02
Datum 23.06.2017
Öppning 13,80
Gårdagen 13,69
Dagshögsta 13,86
Dagslägsta 13,69
52 v. högsta 13,90
52 v. lägsta 10,65
52 v. perf.
Volym (Antal) 2 743 287
Börsvärde (SEK) 133,33 Mrd
Börsen
Kurs för 13,69 GBP från börsen London motsvarar med aktuell växelkurssentspricht GBP/SEK en kurs på 152,02 SEK.

Till aktien Smith & Nephew

Ticker
ISIN GB0009223206
Index FTSE 100, FTSE Allshare

Smith & Nephew Nyckeltal

Börsvärde i SEK 133,33 Mrd
Free float % 98,72
Antal aktier mio. 874,98
Cashflow/aktie i lokal valuta 0,78
Bokvärde/aktie i lokal valuta 3,60
60 dagar vola 40,86
PBV 3,32

Smith & Nephew Historiska kurser

2017-06-23 13,69 2 743 287
2017-06-22 13,82 1 889 074
2017-06-21 13,82 2 492 360
2017-06-20 13,77 1 674 298
2017-06-19 13,71 1 500 141